APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide

Grazyna Galazka, L. Windsor, Henning Birkedal-Hansen, Jeffrey A. Engler

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) can be activated in vitro by multiple mechanisms such as treatment with proteases, organomercurials, oxidants, and detergents. The proposed cysteine switch model for activation suggests that these multiple methods for activation cause the dissociation of the single cysteine residue in the propeptide from the active site zinc. In particular, it has been suggested that organomercurials such as 4-aminophenylmercuric acetate (APMA) work by directly reacting with the sulfhydryl group of this cysteine residue, resulting in its displacement from the active site. However, recent data by Chen et al. [(1993) Biochemistry 32, 10289-10295] demonstrated that modification of this cysteine residue in the propeptide of stromelysin-I by sulfhydryl reagents did not result in an active enzyme as predicted. To investigate the roles that this cysteine residue and the propeptide salt bridge (R74 to D79) might play in file APMA-induced activation of stromelysin-I, we have changed these residues by site-directed mutagenesis. Wild type stromelysin-I and the mutants were all expressed at detectable levels using a recombinant vaccinia virus system and determined to be catalytically competent by zymography. The wild-type stromelysin-I and the cysteine mutants (C75S and C75H) underwent APMA-induced activation as determined by the characteristic reduction in molecular weight associated with activation and by their ability to cleave casein only when activated. On the other hand, mutants R74K, D79A, and C75H/D79A did not undergo APMA- induced activation. These results demonstrate that APMA-induced activation of stromelysin-I involves protein interactions in addition to those with cysteine-75 in the propeptide and also suggest that the R74 to D79 salt bridge may play a role.

Original languageEnglish (US)
Pages (from-to)11221-11227
Number of pages7
JournalBiochemistry
Volume35
Issue number34
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Matrix Metalloproteinase 3
Cysteine
Chemical activation
ritrosulfan
Proteins
Catalytic Domain
Salts
Sulfhydryl Reagents
Mutagenesis
Biochemistry
Vaccinia virus
Site-Directed Mutagenesis
Caseins
4-aminophenylmercuriacetate
Matrix Metalloproteinases
Viruses
Oxidants
Detergents
Zinc
Peptide Hydrolases

ASJC Scopus subject areas

  • Biochemistry

Cite this

APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide. / Galazka, Grazyna; Windsor, L.; Birkedal-Hansen, Henning; Engler, Jeffrey A.

In: Biochemistry, Vol. 35, No. 34, 1996, p. 11221-11227.

Research output: Contribution to journalArticle

@article{cbce1d76ac8f444bbca59f1214dc4864,
title = "APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide",
abstract = "Matrix metalloproteinases (MMPs) can be activated in vitro by multiple mechanisms such as treatment with proteases, organomercurials, oxidants, and detergents. The proposed cysteine switch model for activation suggests that these multiple methods for activation cause the dissociation of the single cysteine residue in the propeptide from the active site zinc. In particular, it has been suggested that organomercurials such as 4-aminophenylmercuric acetate (APMA) work by directly reacting with the sulfhydryl group of this cysteine residue, resulting in its displacement from the active site. However, recent data by Chen et al. [(1993) Biochemistry 32, 10289-10295] demonstrated that modification of this cysteine residue in the propeptide of stromelysin-I by sulfhydryl reagents did not result in an active enzyme as predicted. To investigate the roles that this cysteine residue and the propeptide salt bridge (R74 to D79) might play in file APMA-induced activation of stromelysin-I, we have changed these residues by site-directed mutagenesis. Wild type stromelysin-I and the mutants were all expressed at detectable levels using a recombinant vaccinia virus system and determined to be catalytically competent by zymography. The wild-type stromelysin-I and the cysteine mutants (C75S and C75H) underwent APMA-induced activation as determined by the characteristic reduction in molecular weight associated with activation and by their ability to cleave casein only when activated. On the other hand, mutants R74K, D79A, and C75H/D79A did not undergo APMA- induced activation. These results demonstrate that APMA-induced activation of stromelysin-I involves protein interactions in addition to those with cysteine-75 in the propeptide and also suggest that the R74 to D79 salt bridge may play a role.",
author = "Grazyna Galazka and L. Windsor and Henning Birkedal-Hansen and Engler, {Jeffrey A.}",
year = "1996",
doi = "10.1021/bi960618e",
language = "English (US)",
volume = "35",
pages = "11221--11227",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "34",

}

TY - JOUR

T1 - APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide

AU - Galazka, Grazyna

AU - Windsor, L.

AU - Birkedal-Hansen, Henning

AU - Engler, Jeffrey A.

PY - 1996

Y1 - 1996

N2 - Matrix metalloproteinases (MMPs) can be activated in vitro by multiple mechanisms such as treatment with proteases, organomercurials, oxidants, and detergents. The proposed cysteine switch model for activation suggests that these multiple methods for activation cause the dissociation of the single cysteine residue in the propeptide from the active site zinc. In particular, it has been suggested that organomercurials such as 4-aminophenylmercuric acetate (APMA) work by directly reacting with the sulfhydryl group of this cysteine residue, resulting in its displacement from the active site. However, recent data by Chen et al. [(1993) Biochemistry 32, 10289-10295] demonstrated that modification of this cysteine residue in the propeptide of stromelysin-I by sulfhydryl reagents did not result in an active enzyme as predicted. To investigate the roles that this cysteine residue and the propeptide salt bridge (R74 to D79) might play in file APMA-induced activation of stromelysin-I, we have changed these residues by site-directed mutagenesis. Wild type stromelysin-I and the mutants were all expressed at detectable levels using a recombinant vaccinia virus system and determined to be catalytically competent by zymography. The wild-type stromelysin-I and the cysteine mutants (C75S and C75H) underwent APMA-induced activation as determined by the characteristic reduction in molecular weight associated with activation and by their ability to cleave casein only when activated. On the other hand, mutants R74K, D79A, and C75H/D79A did not undergo APMA- induced activation. These results demonstrate that APMA-induced activation of stromelysin-I involves protein interactions in addition to those with cysteine-75 in the propeptide and also suggest that the R74 to D79 salt bridge may play a role.

AB - Matrix metalloproteinases (MMPs) can be activated in vitro by multiple mechanisms such as treatment with proteases, organomercurials, oxidants, and detergents. The proposed cysteine switch model for activation suggests that these multiple methods for activation cause the dissociation of the single cysteine residue in the propeptide from the active site zinc. In particular, it has been suggested that organomercurials such as 4-aminophenylmercuric acetate (APMA) work by directly reacting with the sulfhydryl group of this cysteine residue, resulting in its displacement from the active site. However, recent data by Chen et al. [(1993) Biochemistry 32, 10289-10295] demonstrated that modification of this cysteine residue in the propeptide of stromelysin-I by sulfhydryl reagents did not result in an active enzyme as predicted. To investigate the roles that this cysteine residue and the propeptide salt bridge (R74 to D79) might play in file APMA-induced activation of stromelysin-I, we have changed these residues by site-directed mutagenesis. Wild type stromelysin-I and the mutants were all expressed at detectable levels using a recombinant vaccinia virus system and determined to be catalytically competent by zymography. The wild-type stromelysin-I and the cysteine mutants (C75S and C75H) underwent APMA-induced activation as determined by the characteristic reduction in molecular weight associated with activation and by their ability to cleave casein only when activated. On the other hand, mutants R74K, D79A, and C75H/D79A did not undergo APMA- induced activation. These results demonstrate that APMA-induced activation of stromelysin-I involves protein interactions in addition to those with cysteine-75 in the propeptide and also suggest that the R74 to D79 salt bridge may play a role.

UR - http://www.scopus.com/inward/record.url?scp=0029774746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029774746&partnerID=8YFLogxK

U2 - 10.1021/bi960618e

DO - 10.1021/bi960618e

M3 - Article

VL - 35

SP - 11221

EP - 11227

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 34

ER -